Madle, Michael
[Other];
Krämer, Isabelle
[Other];
Giesen, Nicola
[Other];
Schwarzbich, Mark-Alexander
[Other];
Wuchter, Patrick
[Other];
Egerer, Gerlinde
[Other];
Ho, Anthony Dick
[Other];
Witzens-Harig, Mathias
[Other]
Rituximab, age and high dose therapy followed by autologus stem cell transplantation are independent prognostic factors for survival in the first line treatment of primary CNS-lymphoma
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Rituximab, age and high dose therapy followed by autologus stem cell transplantation are independent prognostic factors for survival in the first line treatment of primary CNS-lymphoma